CEL-SCI Stock Price, News & Analysis (NYSEAMERICAN:CVM)

$1.90 0.05 (2.70 %)
(As of 11/20/2017 06:58 AM ET)
Previous Close$1.85
Today's Range$1.82 - $1.90
52-Week Range$1.46 - $7.25
Volume141,700 shs
Average Volume176,213 shs
Market Capitalization$23.15 million
P/E RatioN/A
Dividend YieldN/A


CEL-SCI logoCEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for treatment of certain head and neck cancers, and anal warts or cervical dysplasia in human immunodeficiency virus and human papillomavirus co-infected patients and Ligand Epitope Antigen Presentation System (L.E.A.P.S.) technology, with over two investigational therapies, LEAPS-H1N1-DC, a product candidate under development for treatment of pandemic influenza in hospitalized patients, and CEL-2000 and CEL-4000, vaccine product candidates under development for treatment of rheumatoid arthritis.

Industry, Sector and Symbol:
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Sector: N/A
  • CUSIP: N/A
  • Web: www.cel-sci.com
  • Trailing EPS: ($1.30)
  • Net Margins: -25,564.75%
  • Return on Assets: -207.79%
  • Outstanding Shares: 11,830,000

Frequently Asked Questions for CEL-SCI (NYSEAMERICAN:CVM)

What is CEL-SCI's stock symbol?

CEL-SCI trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CVM."

How were CEL-SCI's earnings last quarter?

CEL-SCI Co. (NYSEAMERICAN:CVM) posted its quarterly earnings results on Wednesday, May, 10th. The company reported ($0.05) EPS for the quarter. The company had revenue of $0.02 million for the quarter. View CEL-SCI's Earnings History.

When will CEL-SCI make its next earnings announcement?

CEL-SCI is scheduled to release their next quarterly earnings announcement on Tuesday, December, 12th 2017. View Earnings Estimates for CEL-SCI.

Are investors shorting CEL-SCI?

CEL-SCI saw a drop in short interest in the month of October. As of October 31st, there was short interest totalling 583,301 shares, a drop of 12.8% from the October 13th total of 668,765 shares. Based on an average trading volume of 162,314 shares, the days-to-cover ratio is presently 3.6 days. Currently, 5.3% of the shares of the company are sold short.

Who are some of CEL-SCI's key competitors?

Who are CEL-SCI's key executives?

CEL-SCI's management team includes the folowing people:

  • Geert R. Kersten Esq., Chief Executive Officer, Treasurer, Director (Age 56)
  • Patricia B Prichep, Senior Vice President - Operations, Corporate Secretary (Age 63)
  • John Cipriano, Senior Vice President - Regulatory Affairs (Age 72)
  • Daniel H Zimmerman Ph.D., Senior Vice President - Research, Cellular Immunology (Age 73)
  • Eyal Talor Ph.D., Chief Scientific Officer (Age 58)
  • Alexander G. Esterhazy, Independent Director (Age 73)
  • Peter R. Young Ph.D., Independent Director (Age 70)

How do I buy CEL-SCI stock?

Shares of CEL-SCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CEL-SCI's stock price today?

One share of CEL-SCI stock can currently be purchased for approximately $1.90.

How big of a company is CEL-SCI?

CEL-SCI has a market capitalization of $23.15 million.

How can I contact CEL-SCI?

CEL-SCI's mailing address is 8229 Boone Blvd Ste 802, VIENNA, VA 22182-2634, United States. The company can be reached via phone at +1-703-5069460.

MarketBeat Community Rating for CEL-SCI (NYSEAMERICAN CVM)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  43 (Vote Outperform)
Underperform Votes:  46 (Vote Underperform)
Total Votes:  89
MarketBeat's community ratings are surveys of what our community members think about CEL-SCI and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for CEL-SCI (NYSEAMERICAN:CVM)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 1 Hold Rating, 0 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.00)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for CEL-SCI (NYSEAMERICAN:CVM)

Price Target History for CEL-SCI (NYSEAMERICAN:CVM)

Analysts' Ratings History for CEL-SCI (NYSEAMERICAN:CVM)

DateFirmActionRatingPrice TargetDetails
10/16/2017Dawson JamesReiterated RatingNeutralView Rating Details
(Data available from 11/20/2015 forward)


Earnings History and Estimates Chart for CEL-SCI (NYSEAMERICAN:CVM)

Earnings by Quarter for CEL-SCI (NYSEAMERICAN:CVM)

Earnings History by Quarter for CEL-SCI (NYSEAMERICAN CVM)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
12/12/2017N/AView Earnings Details
5/10/2017Q2 2017($0.05)$0.02 millionViewN/AView Earnings Details
2/9/2017Q116$0.01$0.01 millionViewN/AView Earnings Details
8/10/2016Q316($0.03)$0.13 millionViewN/AView Earnings Details
5/10/2016Q2($0.07)$0.03 millionViewN/AView Earnings Details
5/8/2015Q2 2015($0.12)($0.17)$0.10 million$0.20 millionViewN/AView Earnings Details
2/6/2015Q1 2015($0.09)($0.11)$0.07 million$0.14 millionViewN/AView Earnings Details
5/13/2014Q114($0.11)($0.24)$0.02 million$0.07 millionViewN/AView Earnings Details
2/11/2014Q413($0.11)($0.15)$510.39 millionViewN/AView Earnings Details
1/2/2014Q3($0.27)ViewN/AView Earnings Details
5/14/2013Q213($0.01)$0.07 millionViewN/AView Earnings Details
2/8/2013Q1 2013($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CEL-SCI (NYSEAMERICAN:CVM)

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for CEL-SCI (NYSEAMERICAN:CVM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for CEL-SCI (NYSEAMERICAN CVM)

Insider Trades by Quarter for CEL-SCI (NYSEAMERICAN:CVM)

Insider Trades by Quarter for CEL-SCI (NYSEAMERICAN CVM)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/17/2017Vicente Benjamin AsuncionDirectorSell160,000$0.39$62,400.00
8/25/2017Eyal TalorInsiderSell769$1.91$1,468.79View SEC Filing  
8/16/2017Eyal TalorInsiderSell14,019$2.61$36,589.59View SEC Filing  
10/13/2014Geert R KerstenCEOBuy14,999$0.77$11,549.23View SEC Filing  
12/30/2013Geert R KerstenCEOBuy300,000$0.60$180,000.00View SEC Filing  
10/9/2013Geert R KerstenInsiderBuy8,400$0.79$6,636.00View SEC Filing  
6/19/2013Peter R YoungDirectorBuy25,000$0.24$6,000.00View SEC Filing  
6/14/2013Geert R KerstenInsiderBuy145,120$0.24$34,828.80View SEC Filing  
5/20/2013Geert R KerstenCEOBuy40,000$0.25$10,000.00View SEC Filing  
5/2/2013Geert R KerstenCEOBuy118,700$0.27$32,049.00View SEC Filing  
3/27/2013Peter R YoungDirectorBuy25,000$0.23$5,750.00View SEC Filing  
3/26/2013Geert R KerstenCEOBuy348,125$0.21$73,106.25View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for CEL-SCI (NYSEAMERICAN CVM)


Social Media

Social activity is not available for this stock.



CEL-SCI (NYSEAMERICAN CVM) Chart for Monday, November, 20, 2017
Loading chart…

This page was last updated on 11/20/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.